On February 29, 2024, NICE published interim methods and processes for a new type of guidance called Late Stage Assessment (LSA) in HealthTech and launched a consultation. The document defines the objectives of the LSA, stakeholders involved, timelines, topic selection, approach to assessing the evidence, economic evaluation, and recommendations. The deadline for submitting comments is March 28, 2024.